GlobeNewsWire
13 Dec 2025, 12:18 UTC · 38w ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
Which stocks this story touches
MoonLake Immunotherapeutics is sued for securities fraud after Phase 3 trial failures caused a 90% stock drop.
Continue reading
5 related stories
Search tags
[mutual] BFA announces an investigation into RE/MAX Holdings, Inc.'s board of directors, but this does not indicate a direct relationship between MoonLake and RE/MAX.
[mutual] BFA recovered $420 million from Teva Pharmaceutical Ind. Ltd., but this does not indicate a direct relationship between MoonLake and Teva.
[mutual] BFA recovered over $900 million from Tesla, Inc.'s Board of Directors, but this does not indicate a direct relationship between MoonLake and Tesla.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
9h ago
